3 nominees · 3 ballot items.
Election of three Class II directors; advisory (non-binding) approval of executive compensation (say-on-pay); and ratification of selection of Grant Thornton LLP as independent registered public accounting firm for 2026.
Elect three Class II director nominees (Todd Borgmann, Daniel J. Sajkowski, Bradford T. Sanders) to serve until the 2029 Annual Meeting.
Non-binding advisory (“say-on-pay”) vote to approve the compensation of named executive officers as disclosed for 2025.
This management proposal asks shareholders to cast a non-binding advisory vote to approve the company’s executive compensation disclosures and the compensation practices for named executive officers for 2025. Management seeks approval to validate its redesigned executive compensation program implemented in 2025, which emphasizes pay-for-performance through a mix of base salary, annual cash incentives tied 60% to Adjusted EBITDA with Tax Attributes and 40% to operational metrics, and long-term incentives split 50/50 between PSUs and RSUs. The program was updated after Calumet’s conversion from an MLP to a C-corporation to align pay with investor expectations; PSUs include metrics such as relative TSR (vs. S&P SmallCap 600), net deleveraging, and strategic initiatives, with caps to limit upside when absolute TSR is negative. Management frames the proposal as a reaffirmation of governance practices aimed at aligning management incentives with shareholder value, retention, and balance sheet discipline; the Board recommends a FOR vote citing successful operational and financial progress in 2025, enhanced governance, and prior strong shareholder support (approximately 97% in 2025). The advisory vote is non-binding, but the Board and Compensation Committee will consider the outcome in future pay decisions. The proposal is contextualized by Calumet’s strategic moves (DOE loan to Montana Renewables, debt reductions, and operational improvements) that management links to compensation outcomes.
Ratify the Audit Committee’s selection of Grant Thornton LLP as the company’s independent registered public accounting firm for 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Two Seas Capital LP | 6.8% | 5,960,292 | $214M |
| 2 | Wasserstein Management, L.P. | 5.2% | 4,573,363 | $164M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 3,435,394 | $123M |
| 4 | Adams Asset Advisors, LLC | 3.7% | 3,202,232 | $115M |
| 5 | STATE STREET CORP | 3.5% | 3,080,159 | $111M |
| 6 | BlackRock, Inc. | 2.9% | 2,529,259 | $91M |
| 7 | BlackRock, Inc. | 2.2% | 1,892,247 | $68M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,639,803 | $59M |
| 9 | BANK OF AMERICA CORP /DE/ | 1.2% | 1,007,397 | $36M |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1% | 930,252 | $33M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.